News By Tag
News By Place
CEO OF PARKINSON’S INSTITUTE Shares New Opportunities Regarding Parkinson's Disease
By: Parkinson's Institute and Clinical Center
During the program, Dr. Barlow shared, "The Parkinson's Institute and Clinical Center is beginning its next era of growth and I'm honored to be leading the organization at this exciting time. My plan includes reaching out to the broader Parkinson's community, beyond the Bay Area, and educating the public on what defines the Parkinson's Institute as a critical resource that is uniquely positioned to be at the forefront of new discoveries and therapies. I feel confident our new theories will ultimately lead to improving the lives of those who are living with this disease as well as their family members. My visit to San Diego is just one of the many steps we’re taking to share our knowledge, expand our education and outreach, and engage the Parkinson’s community in our efforts, thus assisting people around the world in recognizing the Parkinson’s Institute and Clinical Center as a catalyst in decoding, treating, and ultimately finding new therapies for Parkinson’s disease."
People living with Parkinson’s throughout the world travel to the Parkinson’s Institute in Northern California to pursue their care and participate in research. Institute research focus areas include: biomarker discovery and clinical research; translational research on genetic forms of Parkinson’s;
Appointed in February 2014 as the second CEO in the Institute’s 25-year history, Dr. Barlow is the former Chief Scientific Officer and Chief Medical Officer of BrainCells, Inc. in San Diego, California, a biotechnology company focused on the discovery and development of small molecules that stimulate adult hippocampal neurogenesis for the treatment of neurological and psychiatric disease using human neural stem cell technology. Prior to her post at BrainCells, she served as the Director of Molecular Neuroscience and Worldwide Therapeutic Area Head for Stroke and Neurodegeneration at Merck Research Laboratories where she was responsible for integration of neuroscience biology, global exploratory, licensing, and full-phase efforts in stroke and neurogenerative disease. Dr. Barlow has held a faculty position in the Laboratory of Genetics at the Salk Institute for Biological Studies in La Jolla, California. She also serves as an advisory board member for several biotechnology companies and disease foundations advancing therapies for rare diseases and disorders of the central nervous system (CNS).
EMS Marketing Consulting, Inc.